|
|
Volumn 293, Issue 1, 2005, Pages 68-75
|
|
New movement in Parkinson's
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINES;
BIOLOGICAL ORGANS;
CELLS;
CYTOLOGY;
DIAGNOSIS;
GENETIC ENGINEERING;
HEALTH CARE;
HEALTH RISKS;
NEUROLOGY;
CLINICAL TRIALS;
LIMB RIGIDITY;
PARKINSON'S DISEASE;
SLEEPING;
WALKING;
DISEASE CONTROL;
ANTIPARKINSON AGENT;
CHAPERONE;
DOPAMINE;
GDNF PROTEIN, HUMAN;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
NERVE GROWTH FACTOR;
NERVE PROTEIN;
PARKIN;
PROTEASOME;
SYNUCLEIN;
UBIQUITIN;
UBIQUITIN PROTEIN LIGASE;
AGING;
ARTICLE;
BIOSYNTHESIS;
CELL DEATH;
CHEMISTRY;
ELECTROSTIMULATION;
GENETICS;
HUMAN;
METABOLISM;
MUTATION;
NERVE CELL;
PARKINSON DISEASE;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PROTEIN FOLDING;
SUBSTANTIA NIGRA;
AGING;
ANTIPARKINSON AGENTS;
CELL DEATH;
DOPAMINE;
ELECTRIC STIMULATION;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HUMANS;
MOLECULAR CHAPERONES;
MUTATION;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NEURONS;
PARKINSON DISEASE;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTEIN FOLDING;
SUBSTANTIA NIGRA;
SYNUCLEINS;
UBIQUITIN;
UBIQUITIN-PROTEIN LIGASES;
|
|
EID: 21544468057
PISSN: 00368733
EISSN: None
Source Type: Journal
DOI: 10.1038/scientificamerican0705-68 Document Type: Review |
|
Times cited : (16)
|
|
References (0)
|
